EPREX®

DRUG3 trials

Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD., Cinnagen

Conditions

Anemia in End-Stage Renal DiseaseRenal AnaemiaRenal Anemia

Phase 3

Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)

CompletedNCT02947438

Shenyang Sunshine Pharmaceutical Co., LTD.Renal Anemia

Start: 2015-12-31End: 2021-10-09Updated: 2022-11-23

Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients

CompletedNCT03408639

CinnagenAnemia in End-Stage Renal Disease

Start: 2016-06-22End: 2017-07-19Updated: 2019-12-18

Phase 4

Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)

TerminatedNCT02522975

Shenyang Sunshine Pharmaceutical Co., LTD.Renal Anaemia

Start: 2015-08-31End: 2019-08-31Updated: 2020-10-22

Related Papers

Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients

American Journal of Nephrology2018-01-0117 citations